120 related articles for article (PubMed ID: 2828006)
1. Humoral hypercalcemia of malignancy in canine lymphosarcoma.
Weir EC; Norrdin RW; Matus RE; Brooks MB; Broadus AE; Mitnick M; Johnston SD; Insogna KL
Endocrinology; 1988 Feb; 122(2):602-8. PubMed ID: 2828006
[TBL] [Abstract][Full Text] [Related]
2. Hypercalcemia in dogs with lymphosarcoma. Biochemical, ultrastructural, and histomorphometric investigations.
Meuten DJ; Kociba GJ; Capen CC; Chew DJ; Segre GV; Levine L; Tashjian AH; Voelkel EF; Nagode LA
Lab Invest; 1983 Nov; 49(5):553-62. PubMed ID: 6314038
[TBL] [Abstract][Full Text] [Related]
3. Two species of adenylate cyclase-stimulating activity in a murine squamous carcinoma model of humoral hypercalcemia of malignancy.
Burtis WJ; Broadus AE; Insogna KL; Weir EC; Stewart AF
Endocrinology; 1986 May; 118(5):1982-8. PubMed ID: 3009144
[TBL] [Abstract][Full Text] [Related]
4. Biochemical and histomorphometric characterization of a rat model for humoral hypercalcemia of malignancy.
Insogna KL; Stewart AF; Vignery AM; Weir EC; Namnum PA; Baron RE; Kirkwood JM; Deftos LM; Broadus AE
Endocrinology; 1984 Mar; 114(3):888-96. PubMed ID: 6546543
[TBL] [Abstract][Full Text] [Related]
5. Bone and kidney adenylate cyclase-stimulating activity produced by a hypercalcemic canine adenocarcinoma line (CAC-8) maintained in nude mice.
Rosol TJ; Capen CC; Brooks CL
Cancer Res; 1987 Feb; 47(3):690-5. PubMed ID: 3467838
[TBL] [Abstract][Full Text] [Related]
6. Frequency and partial characterization of adenylate cyclase-stimulating activity in tumors associated with humoral hypercalcemia of malignancy.
Stewart AF; Insogna KL; Burtis WJ; Aminiafshar A; Wu T; Weir EC; Broadus AE
J Bone Miner Res; 1986 Jun; 1(3):267-76. PubMed ID: 2845726
[TBL] [Abstract][Full Text] [Related]
7. Separation of parathyroid hormone-like activity from transforming growth factor-alpha and -beta in the canine adenocarcinoma (CAC-8) model of humoral hypercalcemia of malignancy.
Merryman JI; Rosol TJ; Brooks CL; Capen CC
Endocrinology; 1989 May; 124(5):2456-63. PubMed ID: 2539981
[TBL] [Abstract][Full Text] [Related]
8. Parathyroid hormone-like adenylate cyclase-stimulating activity from a human carcinoma is associated with bone-resorbing activity.
Klein RF; Strewler GJ; Leung SC; Nissenson RA
Endocrinology; 1987 Feb; 120(2):504-11. PubMed ID: 3026777
[TBL] [Abstract][Full Text] [Related]
9. Co-purification of transforming growth factor beta-like activity with PTH-like and bone-resorbing activities from a tumor associated with humoral hypercalcemia of malignancy.
Insogna KL; Weir EC; Wu TL; Stewart AF; Broadus AE; Burtis WJ; Centrella M
Endocrinology; 1987 May; 120(5):2183-5. PubMed ID: 3494596
[TBL] [Abstract][Full Text] [Related]
10. Humoral hypercalcemia of malignancy in nude mouse model of a canine adenocarcinoma derived from apocrine glands of the anal sac. Biochemical, histomorphometric, and ultrastructural studies.
Rosol TJ; Capen CC; Weisbrode SE; Horst RL
Lab Invest; 1986 Jun; 54(6):679-88. PubMed ID: 3012199
[TBL] [Abstract][Full Text] [Related]
11. Hypercalcemia in dogs with adenocarcinoma derived from apocrine glands of the anal sac. Biochemical and histomorphometric investigations.
Meuten DJ; Segre GV; Capen CC; Kociba GJ; Voelkel EF; Levine L; Tashjian AH; Chew DJ; Nagode LA
Lab Invest; 1983 Apr; 48(4):428-35. PubMed ID: 6300551
[TBL] [Abstract][Full Text] [Related]
12. Pathogenesis of hypercalcemia in nude mice bearing a human renal carcinoma.
Strewler GJ; Wronski TJ; Halloran BP; Miller SC; Leung SC; Williams RD; Nissenson RA
Endocrinology; 1986 Jul; 119(1):303-10. PubMed ID: 3013591
[TBL] [Abstract][Full Text] [Related]
13. Nephrogenous cyclic AMP, adenylate cyclase-stimulating activity, and the humoral hypercalcemia of malignancy.
Godsall JW; Burtis WJ; Insogna KL; Broadus AE; Stewart AF
Recent Prog Horm Res; 1986; 42():705-50. PubMed ID: 3016837
[No Abstract] [Full Text] [Related]
14. Biochemical evaluation of patients with cancer-associated hypercalcemia: evidence for humoral and nonhumoral groups.
Stewart AF; Horst R; Deftos LJ; Cadman EC; Lang R; Broadus AE
N Engl J Med; 1980 Dec; 303(24):1377-83. PubMed ID: 6253785
[TBL] [Abstract][Full Text] [Related]
15. In vitro adenylate cyclase-stimulating activity predicts the occurrence of humoral hypercalcemia of malignancy in nude mice.
Weir EC; Insogna KL; Brownstein DG; Bander NH; Broadus AE
J Clin Invest; 1988 Mar; 81(3):818-21. PubMed ID: 3343341
[TBL] [Abstract][Full Text] [Related]
16. Direct comparison of sustained infusion of human parathyroid hormone-related protein-(1-36) [hPTHrP-(1-36)] versus hPTH-(1-34) on serum calcium, plasma 1,25-dihydroxyvitamin D concentrations, and fractional calcium excretion in healthy human volunteers.
Horwitz MJ; Tedesco MB; Sereika SM; Hollis BW; Garcia-Ocaña A; Stewart AF
J Clin Endocrinol Metab; 2003 Apr; 88(4):1603-9. PubMed ID: 12679445
[TBL] [Abstract][Full Text] [Related]
17. Identification of 1,24(R)-dihydroxyvitamin D3-like bone-resorbing lipid in a patient with cancer-associated hypercalcemia.
Shigeno C; Yamamoto I; Dokoh S; Hino M; Aoki J; Yamada K; Morita R; Kameyama M; Torizuka K
J Clin Endocrinol Metab; 1985 Oct; 61(4):761-8. PubMed ID: 2993347
[TBL] [Abstract][Full Text] [Related]
18. Parathyroid hormone-related protein and transforming growth factor activities in an extract from a breast cancer associated with humoral hypercalcemia of malignancy.
Nagata N; Yasutomo Y; Kugai N; Matsuura Y; Akatsu T; Sugiyama K; Kinoshita T; Takatani O; Mamiya Y; Yamaguchi K
Jpn J Clin Oncol; 1989 Dec; 19(4):353-9. PubMed ID: 2558242
[TBL] [Abstract][Full Text] [Related]
19. Bone changes in hypercalcemia of malignancy in dogs.
Norrdin RW; Powers BE
J Am Vet Med Assoc; 1983 Aug; 183(4):441-4. PubMed ID: 6688616
[TBL] [Abstract][Full Text] [Related]
20. Canine lymphosarcoma: a model for study of the hypercalcemia of cancer.
Heath H; Weller RE; Mundy GR
Calcif Tissue Int; 1980; 30(2):127-33. PubMed ID: 6769560
[No Abstract] [Full Text] [Related]
[Next] [New Search]
